Your browser doesn't support javascript.
loading
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Kleinstern, Geffen; Camp, Nicola J; Goldin, Lynn R; Vachon, Celine M; Vajdic, Claire M; de Sanjose, Silvia; Weinberg, J Brice; Benavente, Yolanda; Casabonne, Delphine; Liebow, Mark; Nieters, Alexandra; Hjalgrim, Henrik; Melbye, Mads; Glimelius, Bengt; Adami, Hans-Olov; Boffetta, Paolo; Brennan, Paul; Maynadie, Marc; McKay, James; Cocco, Pier Luigi; Shanafelt, Tait D; Call, Timothy G; Norman, Aaron D; Hanson, Curtis; Robinson, Dennis; Chaffee, Kari G; Brooks-Wilson, Angela R; Monnereau, Alain; Clavel, Jacqueline; Glenn, Martha; Curtin, Karen; Conde, Lucia; Bracci, Paige M; Morton, Lindsay M; Cozen, Wendy; Severson, Richard K; Chanock, Stephen J; Spinelli, John J; Johnston, James B; Rothman, Nathaniel; Skibola, Christine F; Leis, Jose F; Kay, Neil E; Smedby, Karin E; Berndt, Sonja I; Cerhan, James R; Caporaso, Neil; Slager, Susan L.
Afiliação
  • Kleinstern G; Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  • Camp NJ; Huntsman Cancer Institute and Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT.
  • Goldin LR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Vachon CM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  • Vajdic CM; Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, Australia.
  • de Sanjose S; CIBER de Epidemiología y Salud Pública, Barcelona, Spain.
  • Weinberg JB; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Institute d'Investigacio Biomedica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Benavente Y; Department of Medicine and.
  • Casabonne D; Department of Immunology, Duke University Medical Center, Durham, NC.
  • Liebow M; Durham Veterans Affairs Medical Center, Durham, NC.
  • Nieters A; CIBER de Epidemiología y Salud Pública, Barcelona, Spain.
  • Hjalgrim H; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Institute d'Investigacio Biomedica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Melbye M; CIBER de Epidemiología y Salud Pública, Barcelona, Spain.
  • Glimelius B; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Institute d'Investigacio Biomedica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Adami HO; Division of General Internal Medicine, Mayo Clinic, Rochester, MN.
  • Boffetta P; Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Baden-Württemberg, Germany.
  • Brennan P; Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.
  • Maynadie M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • McKay J; Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen, Denmark.
  • Cocco PL; Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Shanafelt TD; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Call TG; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Norman AD; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Hanson C; International Agency for Research on Cancer, Lyon, France.
  • Robinson D; Registre des Hémopathies Malignes de Côte d'Or, INSERM UMR1231, Université de Bourgogne-Franche-Comté, Dijon, France.
  • Chaffee KG; International Agency for Research on Cancer, Lyon, France.
  • Brooks-Wilson AR; Department of Medical Sciences and Public Health, Occupational Health Section, University of Cagliari, Monserrato, Italy.
  • Monnereau A; Division of Hematology and.
  • Clavel J; Division of Hematology and.
  • Glenn M; Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  • Curtin K; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Conde L; Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  • Bracci PM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
  • Morton LM; Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada.
  • Cozen W; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
  • Severson RK; Registre des Hémopathies Malignes de la Gironde, Institut Bergonié, University of Bordeaux, INSERM, Team EPICENE, UMR 1219, Bordeaux, France.
  • Chanock SJ; Epidemiology of Childhood and Adolescent Cancers Group, INSERM, Center of Research in Epidemiology and Statistics Sorbonne Paris Cité, Paris, France.
  • Spinelli JJ; Université Paris Descartes, Paris, France.
  • Johnston JB; Epidemiology of Childhood and Adolescent Cancers Group, INSERM, Center of Research in Epidemiology and Statistics Sorbonne Paris Cité, Paris, France.
  • Rothman N; Université Paris Descartes, Paris, France.
  • Skibola CF; Huntsman Cancer Institute and Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT.
  • Leis JF; Huntsman Cancer Institute and Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT.
  • Kay NE; UCL Cancer Institute, London, United Kingdom.
  • Smedby KE; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA.
  • Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Cerhan JR; Department of Preventive Medicine and.
  • Caporaso N; Norris Comprehensive Cancer Center, USC Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Slager SL; Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, MI.
Blood ; 131(23): 2541-2551, 2018 06 07.
Article em En | MEDLINE | ID: mdl-29674426

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Polimorfismo de Nucleotídeo Único / Linfocitose Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Polimorfismo de Nucleotídeo Único / Linfocitose Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article